Skip to main content
Clinical Trials/NCT05919745
NCT05919745
Not yet recruiting
Phase 4

Patient Perception of Pain Following Extraction and Bone Graft Surgery With or Without Preemptive Ibuprofen: A Randomized Clinical Trial

Marquette University1 site in 1 country50 target enrollmentStarted: October 2023Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Enrollment
50
Locations
1
Primary Endpoint
Difference in patient-reported postoperative pain between test and control group

Overview

Brief Summary

The goal of this randomized clinical trial is to compare patient-reported pain and oral health-related quality of life during the first postoperative week following extraction and bone graft surgery in patients who received preemptive ibuprofen versus placebo. Participants will receive ibuprofen 600mg or placebo by mouth with water 1 hour prior to extraction and bone graft surgery.

The primary question it aims to answer is:

• Does preemptive ibuprofen have an effect on postoperative pain 1 hour following extraction and bone graft surgery compared to placebo?

Secondary questions are:

  • Does preemptive ibuprofen have an effect on pain during the first 3 postoperative hours and 7 postoperative days following extraction and bone graft surgery compared to placebo?
  • Does preemptive ibuprofen have an effect on oral health-related quality of life during the 7 postoperative days following extraction and bone graft surgery compared to placebo?

Detailed Description

The null hypothesis of this randomized clinical trial is that there is no difference in patient-reported pain and oral health-related quality of life during the first postoperative week following extraction and bone graft surgery between patients who received 600mg of preemptive ibuprofen versus placebo.

Participants will receive ibuprofen 600mg (test group) or placebo (control group) per os 1 hour prior to extraction and bone graft surgery. Researchers and patients will be blinded to the group assignment. Both groups will be given rescue medication in the form of 1,000 mg tabs of acetaminophen every 6 hours as needed for pain (maximum allowed daily dose 4,000 mg per FDA) and will be allowed to receive ibuprofen or other analgesic medication as needed if pain is not controlled by acetaminophen alone. The subjects will receive the rescue medication pills at the end of the surgical appointment.

Patient-reported pain will be collected by Visual Analogue Scale (VAS) before surgery, every hour for the first 3 postoperative hours and on postoperative days 1-7. VAS for patient-reported swelling will also be recorded at the same time points. Number of rescue medications will be recorded at the same postoperative time points. Oral health-related quality of life as expressed by Oral Health Impact Profile-14 (OHIP-14) questionnaire will be reported before surgery and on postoperative days 2, 5 and 7. Questionnaires on dental anxiety (Modified Dental Anxiety Scale), oral health literacy (Rapid estimate of Adult Literacy in Dentistry 30 Short Form), fear of pain (Fear of pain questionnaire-9) and pain catastrophizing (Pain catastrophizing scale) will be collected prior to surgery and will be evaluated as pain modifiers. Anticipated pain will be reported prior to surgery and questions on comparison between actual and anticipated pain and willingness to undergo a similar procedure again will be asked on days 1 and 7. Surgical and demographic data as well as medical history will be collected on the day of surgery. Clinical wound healing observations will be recorded on day 7.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Ibuprofen group or Test Group

Experimental

Subjects will be given ibuprofen 600mg tab 1h prior to surgery.

Intervention: Ibuprofen 600 mg (Drug)

Ibuprofen group or Test Group

Experimental

Subjects will be given ibuprofen 600mg tab 1h prior to surgery.

Intervention: Acetaminophen (Drug)

Placebo group or Control group

Placebo Comparator

Subjects will be given a placebo tab 1h prior to surgery.

Intervention: Placebo (Drug)

Placebo group or Control group

Placebo Comparator

Subjects will be given a placebo tab 1h prior to surgery.

Intervention: Acetaminophen (Drug)

Outcomes

Primary Outcomes

Difference in patient-reported postoperative pain between test and control group

Time Frame: 1 hour following extraction and bone graft surgery

Visual Analogue Scale will be used to measure patient-reported pain. Its score range from 0-100 and the higher the score, the worse the reported pain is. Specifically, zero represents no pain and 100 represents the worst pain imaginable.

Secondary Outcomes

  • Difference in Oral Health Impact Profile-14 between test and control group(Postoperative days 2, 5 and 7 following extraction and bone graft surgery)
  • Difference in patient-reported postoperative pain between test and control group(Postoperative hours 2 and 3, and postoperative days 1, 2, 3, 4, 5, 6 and 7 following extraction and bone graft surgery.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vrisiis Kofina

Director, Advanced Education in Periodontics Program, Assistant Professor of Periodontics

Marquette University

Study Sites (1)

Loading locations...

Similar Trials